血液分離市場報告：2031 年趨勢、預測與競爭分析

全球血液白血病市場未來前景光明，血液中心和醫院市場都存在巨大機會。預計到 2031 年全球白血球分離術市場規模將達到 25 億美元，2025 年至 2031 年的複合年成長率為 7.5%。市場的主要驅動力是慢性腎臟病盛行率的上升、政府鼓勵捐血的宣傳活動增多以及對血液成分的需求不斷成長。

• 根據Lucintel的預測，離心法廣泛應用於製備新鮮冷凍血漿和濃縮紅血球等血液成分，在預測期內，離心法仍將佔據最大佔有率。
• 根據最終用途，血液中心在預測期內預計仍將佔據較大的佔有率。
• 預計北美在整個預測期內仍將是最大的地區，這是由於該地區人口擴大採用先進的血液分離系統以及血液相關疾病的患病率不斷上升。

血液分離市場的策略性成長機會

血液成分分析市場在各個關鍵應用領域提供了多種策略成長機會。這些機會是由技術進步和對有效治療日益成長的需求所推動的。

• 腫瘤學應用：由於針對癌細胞的新型分離術已顯示出良好的效果，因此腫瘤學應用具有巨大的成長潛力。血液分離技術在癌症治療的應用正在不斷擴大。
• 治療自體免疫疾病：血液分離術擴大被應用於治療自體免疫疾病，提供標靶治療，從而改善患者的治療效果。該應用是市場的一個主要成長領域。
• 擴展到新興市場：由於醫療保健投資的增加和患者數量的增加，擴展到新興市場，尤其是亞太市場，提供了巨大的成長機會。市場參與企業正致力於向這些地區擴張。
• 技術創新：對新型血液分離技術（如自動化系統和改進的過濾器）的投資，透過提高治療效率和患者舒適度提供了成長機會。技術進步正在推動市場成長。
• 監管部門的核准和支持：獲得新型血液分離設備和治療方法的監管核准，有助於引入創新解決方案並擴大市場範圍，從而提供成長機會。

這些策略性成長機會正在透過擴大治療應用、拓寬市場範圍和促進技術創新來推動血液白血病市場向前發展。企業正專注於這些領域以挖掘市場潛力。

血液分離市場促進因素與挑戰

血液白血球分離術市場受到各種促進因素​​和挑戰的影響，這些促進因素和挑戰決定了其成長。技術進步、監管因素和經濟狀況在市場動態中發揮關鍵作用。

血液成分分析市場受以下因素驅動：

• 技術進步：自動化系統和改進的過濾器等血液分離技術的創新正在提高治療的準確性和效率，從而推動市場成長。
• 採用率不斷提高：在癌症和自體免疫疾病等各種治療應用中，採用血液分離技術的情況正在增加，從而增加了市場需求。
• 監管支援：監管部門對新型血液透析設備和治療方法的核准和支持正在推動創新和產品引進，從而加速市場成長。
• 增加醫療保健投資：醫療保健基礎設施投資的增加，尤其是在新興市場，正在推動血液分離服務和技術的擴展。
• 擴大應用範圍：血液白血球分離技術在各個醫學學科中的應用日益廣泛，為市場成長和創新創造了新的機會。

血液分離市場面臨的挑戰包括：

• 高成本：先進的血液分離技術和治療的成本高昂，可能會限制其取得和採用，尤其是在發展中地區。
• 監管障礙：滿足新型血液透析設備和治療方法的複雜監管要求可能會延遲產品核准和市場進入。
• 製造的複雜性：血液透析設備和消耗品的製造很複雜，為擴大生產和維持品質帶來了挑戰。

血液白血球分離術市場受技術進步、日益普及和監管支援的推動，但面臨高成本和監管障礙等挑戰。克服成長動力和挑戰對於市場的成功至關重要。

目錄

第1章執行摘要

第動態章。

• 簡介、背景和分類
• 供應鏈
• 產業促進因素與挑戰

第 3 章 市場趨勢與預測分析（2019-2031）

• 宏觀經濟趨勢（2019-2024）與預測（2025-2031）
• 全球血液分離市場趨勢（2019-2024 年）及預測（2025-2031 年）
• 全球血液透析市場按產品類型分類
  • 耗材和試劑
  • 軟體
  • 裝置
• 全球血液透析市場（依技術分類）
  • 離心
  • 膜分離
  • 選擇性吸附
• 全球血液透析市場（按程序分類）
  • 捐贈者/自動血液分離術
  • 治療性血液分離術
• 全球血液透析市場（按最終用途分類）
  • 血液中心
  • 醫院
  • 其他

第 4 章區域市場趨勢與預測分析（2019-2031 年）

• 全球血液透析市場按區域分類
• 北美血液採集市場
• 歐洲血液透析市場
• 亞太地區血液採集市場
• 世界其他地區的血液成分分析市場

第5章 競爭分析

• 產品系列分析
• 營運整合
• 波特五力分析

第6章 成長機會與策略分析

• 成長機會分析
  • 全球血液分離市場成長機會（依產品類型）
  • 全球血液分離市場按技術分類的成長機會
  • 全球血液分離市場成長機會（按程序分類）
  • 全球血液分離市場成長機會（依最終用途分類）
  • 全球血液分離市場各區域成長機會
• 全球血液分離市場的新趨勢
• 戰略分析
  • 新產品開發
  • 全球血液透析市場產能擴張
  • 全球血液分離市場中的企業合併
  • 認證和許可

第7章主要企業簡介

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

The future of the global apheresis market looks promising with opportunities in the blood center and hospital markets. The global apheresis market is expected to reach an estimated $2.5 billion by 2031 with a CAGR of 7.5% from 2025 to 2031. The major drivers for this market are the rising prevalence of chronic renal diseases, increasing government campaigns encouraging blood donation, and expanding demand for blood components.

• Lucintel forecasts that, within the method category, the centrifugation segment will remain the largest segment over the forecast period due to its widespread adoption in the preparation of blood components, including fresh frozen plasma and packed red blood cells.
• Within the end use category, blood centers will remain a larger segment over the forecast period.
• In terms of region, North America will remain the largest region over the forecast period due to rising adoption of cutting-edge apheresis systems and growth in the incidence of blood-related illnesses among the population in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Apheresis Market

The apheresis market is influenced by several emerging trends that are transforming the industry. These trends reflect advancements in technology and shifts in treatment approaches, shaping the future of apheresis therapies.

• Technological Advancements: Innovations in apheresis technology, such as automated systems and improved filters, are enhancing treatment precision and patient comfort. These advancements are driving growth by making apheresis more efficient and accessible.
• Expansion in Therapeutic Applications: Apheresis is increasingly used for a wider range of conditions, including autoimmune diseases, cancer, and genetic disorders. This expansion is broadening the market and increasing demand for specialized apheresis therapies.
• Growth in Emerging Markets: Emerging markets, particularly in Asia-Pacific, are experiencing rapid growth in apheresis due to rising healthcare investments and increasing patient populations. This trend is opening new opportunities for market players in these regions.
• Integration of Data Analytics: The use of data analytics and AI in apheresis procedures is improving treatment outcomes and operational efficiency. These technologies are enabling more personalized and effective apheresis treatments.
• Regulatory Support and Approvals: Increasing regulatory approvals and support for new apheresis devices and therapies are accelerating market growth. Governments and health authorities are facilitating the introduction of innovative apheresis solutions.

These trends are reshaping the apheresis market by driving technological advancements, expanding therapeutic applications, and opening new growth opportunities. The focus on innovation and regulatory support is enhancing the effectiveness and reach of apheresis therapies.

Recent Developments in the Apheresis Market

Key developments in the apheresis market reflect technological advancements, regulatory changes, and increasing adoption across various therapeutic areas. These developments are driving growth and expanding the scope of apheresis treatments globally.

• Advanced Apheresis Technologies: New automated apheresis systems with enhanced precision and efficiency have been introduced, improving patient outcomes and treatment consistency. These innovations are setting new standards in the market.
• Regulatory Approvals for New Devices: Recent regulatory approvals for advanced apheresis devices have facilitated market expansion. These approvals are enabling the introduction of new technologies and expanding the range of available apheresis treatments.
• Increased Adoption in Oncology: The use of apheresis in oncology has increased, with new therapies targeting cancer cells showing promising results. This growth reflects a broader application of apheresis in cancer treatment.
• Expansion in Emerging Markets: The apheresis market is expanding rapidly in emerging markets due to increasing healthcare infrastructure and investments. This growth is opening new opportunities for market players and driving global market expansion.
• Innovative Therapeutic Applications: New therapeutic applications of apheresis are being explored, including treatments for autoimmune diseases and genetic disorders. These innovations are broadening the market and increasing demand for apheresis therapies.

These developments are significantly impacting the apheresis market by driving technological advancements, regulatory approvals, and expanding therapeutic applications. The market is growing rapidly due to these innovations and increasing global demand.

Strategic Growth Opportunities for Apheresis Market

The apheresis market offers several strategic growth opportunities across key applications. These opportunities are driven by advancements in technology and increasing demand for effective treatments.

• Oncology Applications: There is significant growth potential in oncology applications, with new apheresis therapies targeting cancer cells showing promising results. This opportunity is expanding the use of apheresis in cancer treatment.
• Autoimmune Disease Treatments: Apheresis is increasingly used for treating autoimmune diseases, providing targeted therapies that improve patient outcomes. This application is a key growth area in the market.
• Emerging Markets Expansion: Expanding into emerging markets, particularly in Asia-Pacific, offers substantial growth opportunities due to rising healthcare investments and increasing patient populations. Market players are focusing on these regions for expansion.
• Technological Innovations: Investing in new apheresis technologies, such as automated systems and improved filters, presents growth opportunities by enhancing treatment efficiency and patient comfort. Technological advancements are driving market growth.
• Regulatory Approvals and Support: Gaining regulatory approvals for new apheresis devices and therapies opens up growth opportunities by facilitating the introduction of innovative solutions and expanding market reach.

These strategic growth opportunities are driving the apheresis market forward by expanding therapeutic applications, increasing market reach, and fostering innovation. Companies are focusing on these areas to capitalize on market potential.

Apheresis Market Driver and Challenges

The apheresis market is influenced by various drivers and challenges that shape its growth. Technological advancements, regulatory factors, and economic conditions play key roles in market dynamics.

The factors responsible for driving the apheresis market include:

• Technological Advancements: Innovations in apheresis technology, including automated systems and improved filters, are enhancing treatment precision and efficiency, driving market growth.
• Increased Adoption: Growing adoption of apheresis for various therapeutic applications, including oncology and autoimmune diseases, is expanding market demand.
• Regulatory Support: Regulatory approvals and support for new apheresis devices and therapies are accelerating market growth by facilitating innovation and product introductions.
• Rising Healthcare Investments: Increased investments in healthcare infrastructure, particularly in emerging markets, are driving the expansion of apheresis services and technologies.
• Expanding Applications: The broadening use of apheresis in diverse medical fields is creating new opportunities for market growth and innovation.

Challenges in the apheresis market are:

• High Costs: The high cost of advanced apheresis technologies and treatments can limit accessibility and adoption, particularly in developing regions.
• Regulatory Hurdles: Navigating complex regulatory requirements for new apheresis devices and therapies can delay product approvals and market entry.
• Manufacturing Complexity: The complexity of manufacturing apheresis equipment and supplies can pose challenges in scaling up production and maintaining quality.

The apheresis market is driven by technological advancements, increased adoption, and regulatory support, but faces challenges such as high costs and regulatory hurdles. Addressing these challenges while capitalizing on growth drivers is crucial for market success.

List of Apheresis Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies apheresis companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the apheresis companies profiled in this report include-

• Kawasumi Laboratories
• Nikkiso
• Haemonetics Corporation
• Asahi Kasei Medical
• Cerus Corporation
• Kaneka Corporation
• Charles River Laboratories International
• B. Braun Melsungen
• Fresenius Kabi
• Terumo BCT

Apheresis by Segment

The study includes a forecast for the global apheresis market by product type, method, procedure, end use, and region.

Apheresis Market by Product Type [Analysis by Value from 2019 to 2031]:

• Disposable and Reagents
• Software
• Devices

Apheresis Market by Method [Analysis by Value from 2019 to 2031]:

• Centrifugation
• Membrane Separation
• Selective Adsorption

Apheresis Market by Procedure [Analysis by Value from 2019 to 2031]:

• Donor/Automated Apheresis
• Therapeutic Apheresis

Apheresis Market by End Use [Analysis by Value from 2019 to 2031]:

• Blood Centers
• Hospitals
• Others

Apheresis Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Apheresis Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below image highlights recent developments by major apheresis producers in key regions: the USA, China, India, Japan, and Germany

• United States: In the U.S., recent developments include the introduction of advanced apheresis technologies and increased adoption of automated systems. Regulatory approvals for new apheresis devices and therapies, particularly for oncology and autoimmune disorders, have accelerated market growth.
• China: China is witnessing significant growth in the apheresis market due to government initiatives supporting healthcare advancements. There is a rise in local manufacturing of apheresis equipment and an increase in clinical applications, particularly for treating blood disorders and cancer.
• Germany: Germany has seen advancements in apheresis technologies, with a focus on improving efficiency and patient comfort. The market is supported by strong healthcare infrastructure and research institutions developing new therapeutic applications for apheresis, especially in hematology and oncology.
• India: In India, the apheresis market is expanding due to increasing healthcare access and investments in medical technology. There is a growing focus on improving apheresis procedures for treating various diseases, supported by government health programs and private sector investments.
• Japan: The Japanese apheresis market is driven by technological innovations and a growing demand for advanced therapeutic solutions. The country is focusing on developing new apheresis technologies and expanding their use in treating chronic diseases and cancer.

Features of the Global Apheresis Market

Market Size Estimates: Apheresis market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Apheresis market size by various segments, such as by product type, method, procedure, end use, and region in terms of value ($B).

Regional Analysis: Apheresis market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, methods, procedures, end uses, and regions for the apheresis market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the apheresis market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the apheresis market by product type (disposable and reagents, software, and devices), method (centrifugation, membrane separation, and selective adsorption), procedure (donor/automated apheresis and therapeutic apheresis), end use (blood centers, hospitals, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Apheresis Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Apheresis Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Apheresis Market by Product Type
  • 3.3.1: Disposable and Reagents
  • 3.3.2: Software
  • 3.3.3: Devices
• 3.4: Global Apheresis Market by Method
  • 3.4.1: Centrifugation
  • 3.4.2: Membrane Separation
  • 3.4.3: Selective Adsorption
• 3.5: Global Apheresis Market by Procedure
  • 3.5.1: Donor/Automated Apheresis
  • 3.5.2: Therapeutic Apheresis
• 3.6: Global Apheresis Market by End Use
  • 3.6.1: Blood Centers
  • 3.6.2: Hospitals
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Apheresis Market by Region
• 4.2: North American Apheresis Market
  • 4.2.1: North American Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.2.2: North American Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.3: European Apheresis Market
  • 4.3.1: European Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.3.2: European Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.4: APAC Apheresis Market
  • 4.4.1: APAC Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.4.2: APAC Apheresis Market by End Use: Blood Centers, Hospitals, and Others
• 4.5: ROW Apheresis Market
  • 4.5.1: ROW Apheresis Market by Method: Centrifugation, Membrane Separation, and Selective Adsorption
  • 4.5.2: ROW Apheresis Market by End Use: Blood Centers, Hospitals, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Apheresis Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Apheresis Market by Method
  • 6.1.3: Growth Opportunities for the Global Apheresis Market by Procedure
  • 6.1.4: Growth Opportunities for the Global Apheresis Market by End Use
  • 6.1.5: Growth Opportunities for the Global Apheresis Market by Region
• 6.2: Emerging Trends in the Global Apheresis Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Apheresis Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Apheresis Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Kawasumi Laboratories
• 7.2: Nikkiso
• 7.3: Haemonetics Corporation
• 7.4: Asahi Kasei Medical
• 7.5: Cerus Corporation
• 7.6: Kaneka Corporation
• 7.7: Charles River Laboratories International
• 7.8: B. Braun Melsungen
• 7.9: Fresenius Kabi
• 7.10: Terumo BCT